Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Geron Corporation GERN

Sector: Healthcare | Sub-Sector: Biotechnology

Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
Price: $4.13 Volume: 1.6m
Change: +$0.04 % Change: +0.98%
Day High/Low: 4.15/3.96 52 Week High/Low: 4.67/1.76
Last Traded: July 30, 2015 12:00 Transaction Volume: 1
Open: 4.06 Previous Close: 4.09
Bid: 4.00 Ask: 4.79
Bid Size: 1000 Ask Size: 100
Market Cap: 652.9m Shares Out: 158.1m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Stock picks including a coal play

Some pharma recommendations also provided

J.W. Cotton   November 4, 2009
0 stars

Profiting from the 'picks and shovels' of stem cell research

When a race is fueled by hope and greed, failure and economic ruin usually waits at the finish line

Andrew Mickey   January 27, 2009
0 stars

Make money from the next emerging boom

Surprising company keeps reinventing itself

Andrew Mickey   November 25, 2008
0 stars

Cash-rich companies for the bear-market bounce

Dow headed back to 11,000 by year end

Jason Schwarz   November 7, 2008
0 stars

Latest Bullboard Posts